Promote Sponsor
verified SJR 3,6 · Q1 • database Scopus / SJR & Web of Science indexed
Alzheimer's and Dementia
United States · John Wiley and Sons Inc
workspace_premium Q1 — Epidemiology lock Subscription Unclaimed

Alzheimer's and Dementia

Alzheimer's and Dementia is a journal indexed in SJR in Epidemiology and Neurology (clinical) with an H index of 178. It has an SJR impact factor of 3,6 and it has a best quartile of Q1. It has an SJR impact factor of 3,6.

Alzheimer's and Dementia focuses its scope in these topics and keywords: disease, alzheimers, cognitive, dementia, pet, study, screening, patients, tau, alzheimer’s, ...

ISSN: 1552-5260
Editorial: John Wiley and Sons Inc
Category: Epidemiology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
3,6 Q1
H-index 178
Tasa de Aceptación pie_chart
22% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

3,6

H-index

178

Docs (year)

729

Docs 3y

1635

Total refs

42001

Cites 3y

11241

Citable 3y

1115

Cites/Doc 2y

6.85

Ref/Doc

57.61

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Centers for Medicare and Medicaid Services proposes new telehealth services for Medicare beneficiaries

View more

Worldwide Alzheimer's Disease Neuroimaging Initiative

View more

Diagnosis and assessment of Alzheimer's disease in diverse populations

View more

Development of a straightforward and sensitive scale for MCI and early AD clinical trials

View more

Current and past leisure time physical activity in relation to risk of Alzheimer's disease in older adults

View more

Computerized diagnosis of mild cognitive impairment

View more

Community perceptions related to brain donation: Evidence for intervention

View more

Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." A Canadian perspective

View more

Cognitive changes and dementia risk after traumatic brain injury: Implications for aging military personnel

View more

Closer caregiver and care-recipient relationships predict lower informal costs of dementia care: The Cache County Dementia Progression Study

View more

Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease

View more

Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults

View more
SHOW MORE ARTICLES

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

View more

[O1-03-06]: Human amyloid-imaging studies with Pittsburgh Compound-B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition?

View more

Blood DNA methylation as a potential biomarker of dementia: A systematic review

View more

Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010

View more

Apolipoprotein E genotype and the association between C-reactive protein and postoperative delirium: Importance of gene-protein interactions

View more

Alzheimer's disease: The next frontier - Special Report 2017

View more

Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation

View more

Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2

View more

[P4-216]: COMPARISON OF GRAY MATTER VOLUME AND FRACTIONAL ANISOTROPY IN MILD COGNITIVE IMPAIRMENT PATIENTS WITH AND WITHOUT AMYLOIDOPATHY

View more

[P3-528]: PROSPECTIVE ASSOCIATIONS BETWEEN VITAMINS, METABOLITES, AND OVERALL DEMENTIA IN THE OLDEST-OLD

View more

[P3-191]: SLEEP PROBLEMS AND CHANGES IN AD BIOMARKERS ARE PREDICTIVE OF PERSONS WHO ULTIMATELY DEVELOP AD: FINDINGS FROM SUBGROUP META-ANALYSIS ON SLEEP AND ALZHEIMER's DISEASE

View more

[P2-301]: DISEASE STAGING IN FRONTOTEMPORAL DEMENTIA AND ALZHEIMER'S DISEASE: THE CONTRIBUTION OF THE FRONTOTEMPORAL DEMENTIA RATING SCALE (FTD-FRS) IN A 12-MONTH FOLLOW-UP STUDY

View more

FAQS